Protagonist Therapeutics (PTGX) Revenue & Revenue Breakdown
Protagonist Therapeutics Revenue Highlights
Latest Revenue (Q)
$28.32M
Main Segment (Y)
Development Services
Main Geography (Y)
License and Collaboration Agreement
Protagonist Therapeutics Revenue by Period
Protagonist Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | - | -100.00% |
| 2023-12-31 | $60.00M | 125.73% |
| 2022-12-31 | $26.58M | -2.84% |
| 2021-12-31 | $27.36M | -4.44% |
| 2020-12-31 | $28.63M | 12293.07% |
| 2019-12-31 | $231.00K | -99.25% |
| 2018-12-31 | $30.93M | 54.14% |
| 2017-12-31 | $20.06M | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2014-12-31 | - | - |
Protagonist Therapeutics generated - in revenue during NA 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Protagonist Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | $28.32M | -83.40% |
| 2024-12-31 | $170.64M | 3550.01% |
| 2024-09-30 | $4.67M | 12.19% |
| 2024-06-30 | $4.17M | -98.37% |
| 2024-03-31 | $254.95M | 324.92% |
| 2023-12-31 | $60.00M | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | -100.00% |
| 2022-06-30 | $859.00K | -96.66% |
| 2022-03-31 | $25.72M | 198.50% |
| 2021-12-31 | $8.62M | -16.23% |
| 2021-09-30 | $10.29M | 354.13% |
| 2021-06-30 | $2.27M | -63.40% |
| 2021-03-31 | $6.19M | 9.54% |
| 2020-12-31 | $5.65M | -56.92% |
| 2020-09-30 | $13.11M | 110.94% |
| 2020-06-30 | $6.22M | 70.47% |
| 2020-03-31 | $3.65M | 34.13% |
| 2019-12-31 | $2.72M | -34.34% |
| 2019-09-30 | $4.14M | -150.57% |
| 2019-06-30 | $-8.19M | -624.94% |
| 2019-03-31 | $1.56M | -33.70% |
| 2018-12-31 | $2.35M | -61.53% |
| 2018-09-30 | $6.12M | -47.60% |
| 2018-06-30 | $11.67M | 8.28% |
| 2018-03-31 | $10.78M | -4.44% |
| 2017-12-31 | $11.28M | 28.48% |
| 2017-09-30 | $8.78M | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | - |
Protagonist Therapeutics generated $28.32M in revenue during Q1 2025, up -83.40% compared to the previous quarter, and up 47.20% compared to the same period a year ago.
Protagonist Therapeutics Revenue Breakdown
Protagonist Therapeutics Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|
| Development Services | $15.30M | - | - | - |
| License and Collaboration Agreement | - | $18.60M | - | - |
| Financial Service Other | - | - | $1.50M | - |
| License And Collaborative Revenue | - | - | $28.60M | $200.00K |
Protagonist Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 24: Development Services (100.00%).
Quarterly Revenue by Product
| Product/Service | Dec 24 | Sep 24 | Mar 24 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Mar 19 | Sep 18 | Jun 18 | Mar 18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Development Services | $4.70M | $9.70M | $900.00K | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| License and Collaboration Agreement | - | - | - | $900.00K | $25.70M | $10.60M | - | - | - | - | - | - | - | - | - | - | - |
| License And Service | - | - | - | - | - | - | $8.00M | - | - | - | - | - | - | - | - | - | - |
| License And Collaborative Revenue | - | - | - | - | - | - | - | $95.80M | $96.30M | $6.60M | $99.40M | $113.90M | $113.60M | $1.60M | $6.10M | $11.67M | $10.78M |
| Financial Service Other | - | - | - | - | - | - | - | $200.00K | $600.00K | $500.00K | $500.00K | $500.00K | - | - | - | - | - |
Protagonist Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Dec 24: Development Services (100.00%).
Protagonist Therapeutics Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|
| License and Collaboration Agreement | $18.60M | - | - |
| Financial Service Other | - | $1.50M | - |
| License And Collaborative Revenue | - | $28.60M | $200.00K |
Protagonist Therapeutics's latest annual revenue breakdown by geography, as of Dec 21: License and Collaboration Agreement (100.00%).
Quarterly Revenue by Country
| Country | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Mar 19 | Sep 18 | Jun 18 | Mar 18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| License and Collaboration Agreement | $900.00K | $25.70M | $10.60M | - | - | - | - | - | - | - | - | - | - | - |
| License And Service | - | - | - | $8.00M | - | - | - | - | - | - | - | - | - | - |
| License And Collaborative Revenue | - | - | - | - | $95.80M | $96.30M | $6.60M | $99.40M | $113.90M | $113.60M | $1.60M | $6.10M | $11.67M | $10.78M |
| Financial Service Other | - | - | - | - | $200.00K | $600.00K | $500.00K | $500.00K | $500.00K | - | - | - | - | - |
Protagonist Therapeutics's latest quarterly revenue breakdown by geography, as of Jun 22: License and Collaboration Agreement (100.00%).
Protagonist Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ALKS | Alkermes | $1.56B | $390.66M |
| PTCT | PTC Therapeutics | $806.78M | $1.18B |
| KRYS | Krystal Biotech | $290.51M | $96.04M |
| ACLX | Arcellx | $107.94M | $8.13M |
| KYMR | Kymera Therapeutics | $47.07M | $11.48M |
| NAMS | NewAmsterdam Pharma | $45.56M | $2.98M |
| ARWR | Arrowhead Pharmaceuticals | $3.55M | $542.71M |
| CRNX | Crinetics Pharmaceuticals | $1.04M | $361.00K |
| AKRO | Akero Therapeutics | - | - |
| PTGX | Protagonist Therapeutics | - | $28.32M |
| TGTX | TG Therapeutics | - | $141.15M |